F11R and Reoviridae infectious disease: Conversely, genetic ablation via CRISPR/Cas9-mediated knock-out of JAM-A (Fig. 3C) in primary pancreatic CAFs led to a significant decrease in cell death (Fig. 3D) upon reovirus infection.